CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia.

Nathan Herrmann,Zahinoor Ismail,Rhonda Collins,Philippe Desmarais,Zahra Goodarzi,Alexandre Henri-Bhargava,Andrea Iaboni,Julia Kirkham,Fadi Massoud,Andrea Moser,James Silvius,Jennifer Watt,Dallas Seitz

Alzheimer's & dementia (New York, N. Y.)（2022）

引用 3|浏览8

暂无评分

摘要

CCCDTD5 deprescribing recommendations provide evidence-informed recommendations related to cognitive enhancer deprescribing that will facilitate shared decision making among patients, care partners, and clinicians.

查看译文

关键词

cholinesterase inhibitor,cognitive enhancer,dementia,deprescribing,discontinuation,memantine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要